08:35:31 EDT Thu 22 Oct 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Z:TEVA - TEVA PHARMACEUTICAL INDUSTRIES SPON ADS - http://www.tevapharm.com08:35:31 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TEVA - Z0.19.42·9.445.29.484.54219    13.76  6.2508:14:28Oct 1715 min RT 2¢

Recent Trades - Last 10 of 19
Time ETExPriceChangeVolume
08:14:28Z9.43-0.05700
08:14:28Z9.43-0.05403
08:14:28Z9.43-0.05100
08:14:20Z9.4498-0.0302375
08:10:59Z9.4399-0.0401200
08:10:26Z9.4399-0.0401100
08:00:04Z9.42-0.065
08:00:04Z9.43-0.051,000
08:00:04Z9.43-0.05100
08:00:03Z9.42-0.06100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-10-17 18:40U:TEVANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVA
2020-10-15 17:45U:TEVANews ReleaseROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA
2020-10-15 07:30U:TEVANews ReleaseiBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors
2020-10-07 08:00U:TEVANews ReleaseTeva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY ® (fremanezumab-vfrm) Injection Published in Headache
2020-10-05 17:40U:TEVANews ReleaseROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – TEVA
2020-10-05 08:00U:TEVANews ReleaseTeva Canada Announces Availability of Aermony RespiClick ™, an Innovative New Device for the Treatment of Bronchial Asthma
2020-10-05 08:00U:TEVANews ReleaseTeva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
2020-10-02 08:00U:TEVANews ReleaseTeva Launches First Generic Versions of HIV-1 Treatments TRUVADA ® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA ® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets in the U.S.
2020-10-01 12:00U:TEVANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of Investors
2020-10-01 11:06U:TEVANews ReleaseTeva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020
2020-09-30 20:06U:TEVANews ReleaseGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of Investors
2020-09-28 19:00U:TEVANews ReleaseROSEN, GLOBALLY RECOGNIZED COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors with Losses in Excess of $100K to Contact the Firm – TEVA
2020-09-28 08:45U:TEVANews ReleaseSHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2020-09-27 03:12U:TEVANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline –   TEVA
2020-09-25 18:58U:TEVANews ReleaseROSEN, LEADING INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors with Losses in Excess of $100K to Contact the Firm - TEVA